RegulatoryOfficial

AIFA adds YESAFILI aflibercept to simplified anti-VEGF monitoring form for four eye indications

🇮🇹 AIFA · Thu 19 Nov 2026

From 19 November 2026, Italian registry users can select YESAFILI (aflibercept) in the simplified multi-drug form for intravitreal anti-VEGF agents, following Determina Pres/1591/2026.

The Italian Medicines Agency (AIFA) has told users of its Monitoring Registries that YESAFILI (aflibercept) can now be selected in the simplified multi-drug monitoring form for intravitreal (IVT) anti-VEGF medicines. The option is available from 19 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: AIFA ↗

Article written by VigiEye from the official source (AIFA). AI-assisted; check the source before acting.